[HTML][HTML] Biomarkers of effect as determined in human biomonitoring studies on hexavalent chromium and cadmium in the period 2008–2020

C Ventura, BC Gomes, A Oberemm, H Louro… - Environmental …, 2021 - Elsevier
A number of human biomonitoring (HBM) studies have presented data on exposure to
hexavalent chromium [Cr (VI)] and cadmium (Cd), but comparatively few include results on …

[HTML][HTML] Revisiting the Role of NAG across the Continuum of Kidney Disease

R Novak, G Salai, S Hrkac, IK Vojtusek, L Grgurevic - Bioengineering, 2023 - mdpi.com
Acute and chronic kidney diseases are an evolving continuum for which reliable biomarkers
of early disease are lacking. The potential use of glycosidases, enzymes involved in …

TGF-β1, NAG-1, and antioxidant enzymes expression alterations in Cisplatin-induced nephrotoxicity in a rat model: Comparative modulating role of Melatonin, Vit. E …

AAR Mohamed, SI Khater, MMM Metwally, TB Emran… - Gene, 2022 - Elsevier
Cisplatin (CP) is an anticancer medication that is commonly used to treat solid tumors. Its
use is, however, dose-restricted due to nephrotoxicity. We planned to compare the …

[HTML][HTML] Repeated administration of clinical doses of tramadol and tapentadol causes hepato-and nephrotoxic effects in Wistar rats

J Barbosa, J Faria, F Garcez, S Leal, LP Afonso… - Pharmaceuticals, 2020 - mdpi.com
Tramadol and tapentadol are fully synthetic and extensively used analgesic opioids,
presenting enhanced therapeutic and safety profiles as compared with their peers. However …

Carbon dots as fluorescent nanoprobe for the determination of N-acetyl-β-d-glucosaminidase activity

J Ma, H Zhang, F Peng, X Yang, ZL Li, L Sun… - Analytica Chimica …, 2020 - Elsevier
Carbon dots (CDs) were synthesized from p-aminophenol and ethylenediamine via one-
step under mild condition and used as a sensitive fluorescent nanoprobe for the activity …

[PDF][PDF] Sensitivity and Specificity of Urine N-Acetyl-β-D-Glucosaminidase as an Early Biomarker For Acute Kidney Injury

ABH Zulkifli, Z Hafy, AA Rizki - academia.edu
Background The estimated incidence of Acute Kidney Injury (AKI) is two to three cases per
1,000 patients. Seven percent of hospitalized patients and about two-thirds of patients in …